Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A description of variant transthyretin amyloidosis (ATTRv) stage 1 patients and asymptomatic carriers in Spain: the EMPATIa study.
Galán Dávila L, Martinez Valle F, Buades Reinés J, Gonzalez-Moreno J, Losada López I, Sevilla T, Muñoz Beamud F, Bárcena Llona JE, Romero Acebal M, Setaro F, Primiano D, Tarilonte P. Galán Dávila L, et al. Among authors: losada lopez i. Orphanet J Rare Dis. 2024 Sep 6;19(1):323. doi: 10.1186/s13023-024-03304-9. Orphanet J Rare Dis. 2024. PMID: 39242501 Free PMC article.
Biomarkers of axonal damage to favor early diagnosis in variant transthyretin amyloidosis (A-ATTRv).
González-Moreno J, Gragera-Martínez Á, Rodríguez A, Borrachero-Garro C, García-Garrido S, Barceló C, Manovel-Sánchez A, Ribot-Sansó MA, Ibargüen-González L, Gomila R, Muñoz-Beamud F, Losada-López I, Cisneros-Barroso E. González-Moreno J, et al. Among authors: losada lopez i. Sci Rep. 2024 Jan 5;14(1):581. doi: 10.1038/s41598-023-50212-2. Sci Rep. 2024. PMID: 38182630 Free PMC article.
A narrative review and expert recommendations on the assessment of the clinical manifestations, follow-up, and management of post-OLT patients with ATTRv amyloidosis.
Casasnovas C, Lladó L, Borrachero C, Pérez-Santamaría PV, Muñoz-Beamud F, Losada-López IA, Baliellas-Comellas MC, González-Moreno J. Casasnovas C, et al. Among authors: losada lopez ia. Ther Adv Neurol Disord. 2023 Aug 24;16:17562864231191590. doi: 10.1177/17562864231191590. eCollection 2023. Ther Adv Neurol Disord. 2023. PMID: 37655225 Free PMC article. Review.
Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.
Cisneros-Barroso E, Gorram F, Ribot-Sansó MA, Alarcon F, Nuel G, González-Moreno J, Rodríguez A, Hernandez-Rodriguez J, Amengual-Cladera E, Martínez-López I, Ripoll-Vera T, Losada-López I, Heine-Suñer D, Plante-Bordeneuve V. Cisneros-Barroso E, et al. Among authors: losada lopez i. Orphanet J Rare Dis. 2023 Aug 31;18(1):255. doi: 10.1186/s13023-023-02865-5. Orphanet J Rare Dis. 2023. PMID: 37653545 Free PMC article.
Follow-up regimens for carriers of hereditary transthyretin variants.
Losada-López IA, Kapetanovic-García S, Sevilla-Mantecón T, Muñoz-Beamud F. Losada-López IA, et al. Med Clin (Barc). 2023 Mar 10;160(5):213-217. doi: 10.1016/j.medcli.2022.10.002. Epub 2022 Dec 16. Med Clin (Barc). 2023. PMID: 36529555 English, Spanish. No abstract available.
Establishing Occupational Therapy Needs: A Semi-Structured Interview with Hereditary Transthyretin Amyloidosis Patients.
Gayà-Barroso A, González-Moreno J, Rodríguez A, Ripoll-Vera T, Losada-López I, Gili M, Paneque M, Cisneros-Barroso E. Gayà-Barroso A, et al. Among authors: losada lopez i. Int J Environ Res Public Health. 2022 Sep 17;19(18):11721. doi: 10.3390/ijerph191811721. Int J Environ Res Public Health. 2022. PMID: 36141995 Free PMC article.
Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis.
Gayà-Barroso A, González-Moreno J, Rodríguez A, Ripoll-Vera T, Losada-López I, Gili M, Cisneros-Barroso E. Gayà-Barroso A, et al. Among authors: losada lopez i. Int J Environ Res Public Health. 2022 Apr 7;19(8):4464. doi: 10.3390/ijerph19084464. Int J Environ Res Public Health. 2022. PMID: 35457333 Free PMC article.
Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission.
García-Gasalla M, Ferrer JM, Fraile-Ribot PA, Ferre-Beltrán A, Rodríguez A, Martínez-Pomar N, Ramon-Clar L, Iglesias A, Losada-López I, Fanjul F, Pou JA, Llompart-Alabern I, Toledo N, Pons J, Oliver A, Riera M, Murillas J. García-Gasalla M, et al. Among authors: losada lopez i. Can J Infect Dis Med Microbiol. 2021 Aug 2;2021:9965850. doi: 10.1155/2021/9965850. eCollection 2021. Can J Infect Dis Med Microbiol. 2021. PMID: 34422145 Free PMC article.
24 results